Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights
MONT-SAINT-GUIBERT, Belgium, April 04, 2024–(BUSINESS WIRE)–Regulatory News: Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the “Company”), today announces its financial results for the fiscal year 2023 ended...